DatasetName,PDXDC1_S(130) PDXDC1_S(604) PDXDC1_S(623) PDXDC1_S(652) PDXDC1_S(690) PDXDC1_S(708) PDXDC1_S(718) PDXDC1_S(721) PDXDC1_S(722) PDXDC1_S(724) PDXDC1_S(729) PDXDC1_S(736) PDXDC1_S(737) PDXDC1_S(751) PDXDC1_S(757) PDXDC1_S(775) PDXDC1_S(779) PDXDC1_S(79) PDXDC1_T(323) PDXDC1_T(600) PDXDC1_T(680) PDXDC1_T(687) PDXDC1_T(691) PDXDC1_T(692) PDXDC1_T(720) PDXDC1_Y(677),PDXDC1_S(627) PDXDC1_S(631) PDXDC1_S(669) PDXDC1_S(693) PDXDC1_S(694) PDXDC1_S(695) PDXDC1_S(696) PDXDC1_S(709) PDXDC1_S(710) PDXDC1_S(714) PDXDC1_S(728) PDXDC1_S(732) PDXDC1_S(739) PDXDC1_S(740) PDXDC1_S(742) PDXDC1_S(786) PDXDC1_T(414) PDXDC1_T(709)
RM2024_Intensity D4-1___3,,
RB2022_4_PostEndurance,,
FSO2013_Ratio M/L normalized Rep3,0.5369492605974657,0.4701113707235197
SR2019_MCF7_Biol_repl_3,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,
SR2019_LM2_Biol_repl_1,,
RCJD2014_15min_1,,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,
CK2022_7 16-1,,
NJH2025_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_C,0.5482186454663761,
RKK2015_TNF-α/basal,,
JJ2018_Ratio H/M normalized pP2,,
NJH2025_Sub12_MICT_Pre,,
NJH2025_Sub7_MICT_Post,,
DL2023_control-3,,
ZX2022_Control Replicate 2,,
HS2024_6_B_T3,,
JW2015_Intensity pre1,,
IMM2018_normalised rep. int. Empty-3,,
AMK2021_30R_p5,,
FSO2013_Ratio M/L normalized Rep1,0.5581184081905185,0.47253838334177584
SR2019_MDAMB231_Biol_repl_4,,
GF2025_P2_Sph,0.5500581669241262,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,
NJH2025_Sub13_HIIT_Mid,,
CP2009_Ratio M/L,,
NJH2025_Sub7_HIIT_Post,,
KBE2022_Log2_Ex_44_T,0.5495802949587697,
DB2022_Intensity L2,,
TM2022_mock.4h.C,,
AST2020_anti-CD3.2,0.5470495010938888,0.4648741015548177
CW2012_10 µM Erl/control Experiment 1 Replicate B,,
HS2024_7_B_N1,,
FSO2013_Ratio M/L normalized Rep1___1,0.5569166640504738,0.4725561297209746
SAS2015_AZD/DMSO_Exp3,,
RM2024_Intensity D0-2___3,,
RM2024_Intensity D6-1,,
RB2022_8_RecoverySprint,,
RB2022_5_PreEndurance,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,
EP2017_Untreated R#4 normalized log2 ratio,0.5460630715010494,0.5081642896048846
WZ2023_Pu_010_30min,0.5447450765274601,0.46523639583411364
AS2011_Ratio H/L Proteins RNAi_2,,
RB2022_4_PreStrength,,
NJH2024_Sub4_MICT_Post,,
AH2018_LFQ_M_1_X,0.5496259965759426,
RB2022_8_RecoveryEndurance,,
KBE2022_Log2_Ex_14_U,0.5471769131734893,
FSO2013_Ratio M/L normalized Rep3___3,0.5348914379680912,0.4856436507303321
AH2018_TMTMS3_1_C,0.5370424846123728,0.4683157074928943
JJ2018_Ratio H/L normalized___1,,
ZQ2022_C2,0.5523561142424576,
RB2022_5_PreSprint,,
PG2020_Intensity 8h_C,0.551242963953636,0.464059127952354
AH2018_SILAC_MR_2_N,0.5514468093567424,0.458046685241852
MV2014_Ratio M/L normalized A1___2 (2 min),,
TM2022_S2.8h.B,,
MV2014_Ratio M/H normalized B3___1 (30 min),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,
RM2024_Intensity D6-1___2,,
NJH2025_Sub7_MICT_Mid,,
LY2019_P1+,0.5401465512983555,
AS2011_Ratio H/L Proteins Inhi_2,,
BS2014_Log2(Ratio H/L normalized),,
UK2020_HCM_2,,
FSO2013_Ratio H/L normalized Rep2___2,0.540142816809752,0.45537826498568024
EP2017_Pervanadate R#3 normalized log2 ratio,0.5478976999615421,0.46735398679069706
RM2024_Intensity D4-3___3,,
RB2022_5_PreStrength,,
NJH2024_Sub4_MICT_Mid,,
TM2022_S2.4h.A,,
RB2022_5_PostStrength,,
GF2025_P6_Sph,0.5460630695765679,
RB2022_2_PreSprint,,
ZX2022_CB treated Replicate 3,,
RM2024_Intensity D6-2___3,,
WZ2023_Pe_025_10min,0.5393224592954485,0.46587461203875247
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,
AST2020_anti-CD3+PDL2.1,0.5470794767040419,0.46484213645582806
KBE2022_Log2_Ex_34_U,0.549558393569376,
WZ2023_Pu_005_10min,0.5456942147869983,0.4658011952768104
AS2011_Ratio H/L RNAi_2_1,,
NJH2024_Sub9_HIIT_Mid,,
CK2022_9 40-1,,
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,
LG2023_GSK3α-1_intensity,0.5537463777152133,
WZ2023_Pu_025_30min,0.5389725392969857,0.46546498441608924
AH2018_SILAC_MR_2_X,0.5513068784623741,0.45958067715509165
HS2024_4_PD_T2,,
NJH2024_Sub4_HIIT_Pre,,
RB2022_2_RecoverySprint,,
AS2011_Ratio H/L Protein RNAi_1,,
RM2024_Intensity D2-1___2,,
CR2017_Ratio Replicate 1.4,0.5894187333219395,0.4730683344493479
FR2021_Norm.Intensity.B,,
RM2024_Intensity D6-2___1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,
RB2022_5_PostSprint,,
EJN2021_3_Rest_Basal,,
CR2017_Ratio Replicate 1.3,0.5710930405670935,0.44328186090087623
AS2011_Ratio H/L Normalized by Protein RNAi_2,,
KTGR2014_Ratio-Rapa 7 mins,,
AMK2021_120R_p1,,
AH2018_SILAC_3_X,0.5475400489101012,
JJ2018_Ratio M/L normalized pP3,,
AH2018_SILAC_M_2_N,0.5492505405554476,
HS2024_7_PD_T2,,
FSO2013_Ratio H/L normalized Rep1___1,0.553691494095187,0.47649376264565213
AH2018_LFQ_1_C,0.5494691912298684,0.46050180032458804
AS2011_Ratio H/L Normalized Inhi_1_3,,
KBE2022_Log2_Ex_28_T,0.548956254754544,
HS2024_3_B_N1,,
RM2024_Intensity D4-2___3,,
WZ2023_Pe_025_30min,0.5398778038363017,0.46614181142451017
CK2022_11 40-1,,
CW2012_10 µM Erl/control Experiment 3 Replicate B,,
AH2018_SILAC_2_X,0.5478660836550227,
MV2014_Ratio H/M normalized A2___2 (2 min),,
AS2011_Ratio H/L RNAi_1_2,,
KS2014_Intensity E15_1,0.5532198256084471,
FSO2013_Ratio H/L normalized Rep2,0.5452010395420169,0.45580170223717276
WZ2023_Pu_005_20min,0.5454790933230307,0.46563609681149554
NJH2024_Sub10_MICT_Post,,
RM2024_Intensity D2-3___1,,
CR2017_Ratio Replicate 1.5,0.6105130800910139,0.46842808156950766
CW2012_10 µM Gef/control Experiment 2 Replicate B,,
HS2024_7_B_T3,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,
AS2011_Ratio H/L RNAi_1,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,
AH2018_LFQ_M_1_C,0.5477992711899515,0.46299748766741317
NJH2025_Sub7_MICT_Pre,,
SR2019_SKBR3_Biol_repl_2,,
HS2024_9_B_T2,,
KTGR2014_Ratio-AA 7 mins,,
MV2014_Ratio L/H normalized B3___3 (5 min),,
HS2024_3_PD_T1,,
FSO2013_Ratio M/L normalized Rep3___2,0.559316727757137,
SR2019_BT549_Biol_repl_3,,
RCJD2014_20min_mean,,
FR2021_Norm.Intensity.H,,
RB2022_2_PreStrength,,
DB2022_LFQ intensity L1.2,,
HS2024_4_B_N1,,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,
CK2022_1 16-1,,
CK2022_1 200-1,0.5610512016796155,
PG2020_Intensity Mock_10h_D,0.5451144608161956,
SR2019_MCF10A_Biol_repl_2,,
JJ2018_Ratio M/L normalized pP2___2,,
HS2024_6_PD_T1,,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,
RB2022_6_RecoveryEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,
EP2017_Mitotic R#2 normalized log2 ratio,0.5558438029428293,0.45537948847394016
RCJD2014_5min_1,,
RM2024_Intensity D4-1___1,,
DL2023_24h-1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,
TM2022_S2.4h.C,,
SAS2015_PLX/AZD_Exp2,,
CR2017_Ratio Replicate 3.3,0.5434978072718111,0.45778912892368706
PG2020_Intensity 2h_C,0.5416792891050846,
VOI2024_Veh2 di,,
ZX2022_CB treated Replicate 2,,
KBE2022_Log2_Ex_8_T,0.5468758267165608,
NJH2025_Sub10_MICT_Post,,
HS2024_6_I_T3,,
RN2012_L11,0.5498556827049363,0.46017525969106177
AS2011_Ratio H/L Normalized Inhi_2_2,,
IMM2018_normalised rep. int. Empty-1,,
HS2024_5_PD_T1,,
AH2018_LFQ_M_2_C,0.5446533529370032,0.464285509490016
CK2022_3 40-1,,
RBK2021_1260T Early,,
NJH2024_Sub4_HIIT_Post,,
HS2024_4_I_T1,,
YA2020_Reporter_intensity_Cancer_No.5,0.5446176533398661,0.46018513184973375
HH2022_Reporter intensity 8,0.5525285951117025,
ZQ2022_N2,0.5431055830778084,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,
FSO2013_Ratio H/L normalized Rep3___3,0.5258206541000547,0.45444094227050047
AH2018_TMTMS3_2_N,0.5777295121450038,
EJN2021_5_Rest_Basal,,
NJH2025_Sub2_HIIT_Post,,
NJH2025_Sub1_MICT_Post,,
HS2024_9_B_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,
JAW2011_Ratio H/L LS2_1,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,
NJH2024_Sub6_HIIT_Pre,,
AH2018_SILAC_3_N,0.5469290470353163,
YA2020_Reporter_intensity_Normal_No.1,0.5475046599382684,0.46052534592968186
HS2024_3_B_T1,,
JJ2018_Ratio H/L normalized___2,,
RM2024_Intensity D0-2,,
MV2014_Ratio M/L normalized B1___2 (5 min),,
RB2022_7_PostStrength,,
RB2022_1_PostEndurance,,
CR2017_Ratio Replicate 3,0.49223272013638586,0.47678433140914883
SR2019_Hs578T_Biol_repl_3,,
MV2014_Ratio L/H normalized B3___1 (5 min),,
RBK2021_1244T Early,,
RB2022_3_PostSprint,,
NJH2024_Sub13_MICT_Mid,,
KTGR2014_Ratio-AA 2 mins,,
GF2025_P7_Sph,0.5524887197050536,
HS2024_8_I_T3,,
CF2017_EOC 3,0.5463519000032498,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,
HS2024_6_PD_T3,,
DL2023_12h-2,,
RM2024_Intensity D6-3___1,,
FS2019_Ctr1,,
WZ2023_Pu_010_20min,0.5506063062937601,0.4654834869854087
AS2011_Ratio H/L_3,,
CK2022_1 40-1,,
RNJ2017_Log2_ratio_Tsup:Trest_D1,,
CK2022_8 16-1,,
KS2014_Intensity N3,0.562719697800068,
RB2022_4_RecoveryEndurance,,
RB2022_5_RecoveryEndurance,,
JAW2011_Ratio H/L LS1a_2,,
NJH2024_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_N,0.5507618421078679,
FSO2013_Ratio H/M normalized Rep2,0.5359531485936198,0.4710967558412223
RAM2015_Log2 A,0.5472911293007855,0.45427216911740487
HS2024_8_PD_T1,,
JJ2018_Ratio H/L normalized pP2,,
CF2017_OSE 27,0.5522182562093993,
KS2014_Intensity E15_2,0.5646035777912274,0.4630425073728543
BS2014_Log2(Ratio H/L protein),,
PG2020_Intensity 8h_A,0.5507793361829347,
HS2024_7_I_T1,,
VOI2024_Veh3 di,,
RKK2015_TNF-α+SC-514/basal,,
SR2019_JIMT1_Biol_repl_1,,
HW2015_Ratio H/L normalized Exp2,,
HS2024_3_I_N1,,
AH2018_SILAC_M_3_X,0.5480687969404956,
NJH2024_Sub9_HIIT_Post,,
AS2011_Ratio H/L RNAi_1_3,,
GRW2016_Ratio H/L normalized SILAC 1___2,,
NJH2025_Sub1_HIIT_Pre,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,
NJH2024_Sub4_HIIT_Mid,,
VOI2024_0.1uM 2 h_1 di,,
KBE2022_Log2_Ex_6_T,0.548713016689284,
RM2024_Intensity D4-3___1,,
AH2018_LFQ_4_X,0.5409973890795454,0.45870554300510247
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
RB2022_8_PostEndurance,,
NJH2025_Sub4_MICT_Mid,,
YP2020_Intensity C30_R1_mult_log2,,
AST2020_anti-CD3.1,0.546703684042316,0.46404114877626207
NJH2025_Sub4_HIIT_Post,,
EP2017_Untreated R#4 log2 ratio,0.5457952333518002,0.5079286461427523
HS2024_6_B_N1,,
KBE2022_Log2_Ex_27_T,0.5460020176122726,0.4620558492415354
CW2012_10 µM Gef/control Experiment 1 Replicate A,,
VOI2024_0.1uM 24 h_1 mono,,
AMK2021_120R_p5,,
AS2011_Ratio H/L Proteins,,
NJH2024_Sub7_HIIT_Post,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),,
AS2011_Ratio H/L RNAi_2_2,,
RB2022_7_RecoveryStrength,,
AH2018_SILAC_IT_3_X,0.5486835939594106,
JAW2011_Ratio H/L,,
PG2020_Intensity 10h_C,,
FSO2013_Ratio M/L normalized Rep2,0.5453151291452826,0.47531379179091954
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,
HH2022_Reporter intensity 5,0.5525470135827703,
SR2019_HCC1954_Biol_repl_2,,
CK2022_14 40-1,,
RB2022_6_PreSprint,,
NJH2025_Sub12_MICT_Mid,,
PG2020_Intensity 4h_D,0.5416852773046532,
NJH2025_Sub2_MICT_Post,,
AH2018_LFQ_4_C,0.5474407470678593,0.4616985505522092
DL2023_control-1,,
AR2021_ALG 10 μM,0.5488055599553943,0.47428554732243483
JAW2011_Ratio H/L LS2_2,,
AH2018_SILAC_IT_3_N,0.5482565851571441,
EJN2021_4_Rest_Ins,,
RN2012_H05,,0.46747264209710326
NJH2024_Sub7_HIIT_Mid,,
GF2025_P2_Adh,0.5498943703878222,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,
RB2022_8_PostSprint,,
EJN2021_1_Rest_Ins,,
HH2022_Reporter intensity 3,0.5465139825459155,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,
AH2018_SILAC_IT_1_C,0.5463317093315925,
JW2021_After_3,0.5367096037044383,
GF2025_P8_Sph,0.5439068682974921,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,
JJ2018_Ratio M/L normalized pP2___1,,
AH2018_SILAC_2_N,0.5470477446379811,
CK2022_11 200-1,0.5525930552569164,
CK2022_12 200-1,0.548519096162367,
AS2011_Ratio H/L Normalized by Protein RNAi_1,,
RM2024_Intensity D2-1___3,,
NJH2024_Sub1_MICT_Pre,,
HH2022_Reporter intensity 9,0.5517002459387725,
WZ2023_Su_010_20min,0.5487061823283376,0.46485555052802485
AH2018_TMTMS2_2_N,0.5410324091863958,0.46824924072157725
NJH2024_Sub13_MICT_Pre,,
KBE2022_Log2_Ex_41_U,0.5508226680246243,
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,
AH2018_TMTMS3_Pool,0.5795993293295854,
KS2014_Intensity N4,0.5717070016781064,0.4679386770747447
NJH2024_Sub1_HIIT_Post,,
MM2018_Ratio H/L replicate2,,
RM2024_Intensity D4-2___2,,
NJH2024_Sub13_HIIT_Pre,,
CF2017_OSE 26,0.5457194371507629,
CK2022_14 200-1,0.5490267177584378,
SR2019_Hs578T_Biol_repl_1,,
RB2022_7_PostSprint,,
TM2022_mock.4h.A,,
NJH2025_Sub12_HIIT_Pre,,
AH2018_TMTMS3_1_N,0.5676554104735594,
AST2020_anti-CD3+PDL2.2,0.5468897198356417,0.4644208817399713
PG2020_Intensity Mock_10h_A,0.542177915353481,
JW2021_After_2,0.5398341069631493,
NJH2024_Sub2_MICT_Post,,
EJN2021_2_Rest_Ins,,
SR2019_LM2_Biol_repl_4,,
CP2009_Ratio H/M,,
JAW2011_Ratio H/L HS,,
CK2022_13 16-1,,
GF2025_P1_Adh,0.554373624438653,
GF2025_P1_Sph,0.5497007247233182,
EJN2021_5_Ex_Basal,,
HS2024_7_I_T3,,
JJ2018_Ratio H/L normalized pP2___2,,
WZ2023_Pe_010_10min,0.541038690236672,0.4655985733255091
CF2017_EOC 1,0.5451018567018164,0.45893499942299265
CK2022_3 200-1,0.5611821203373388,
AH2018_LFQ_IT_3_C,0.5462925843934582,
SR2019_Hs578T_Biol_repl_2,,
NJH2024_Sub12_HIIT_Post,,
JJ2018_Ratio H/L normalized pP1___2,,
MV2014_Ratio H/L normalized A1___2 (10 min),,
NJH2024_Sub10_MICT_Mid,,
NJH2024_Sub13_MICT_Post,,
BS2014_Log2(Ratio H/L normalized Rep_1),,
RB2022_3_RecoverySprint,,
NJH2025_Sub1_HIIT_Mid,,
RCJD2014_20min_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,
HS2024_6_PD_T2,,
HS2024_5_B_T1,,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,
DL2023_12h-3,,
SR2019_MDAMB231_Biol_repl_2,,
HS2024_3_B_T2,,
RB2022_6_PreStrength,,
CK2022_2 40-1,,
RB2022_1_PostSprint,,
CK2022_4 200-1,0.560385715305818,
JW2021_Before_2,0.563177240910455,
TM2022_S2.12h.A,,
MV2014_Ratio L/M normalized B2___2 (30 min),,
CK2022_5 16-1,,
AR2021_ALG 1 μM,0.5451430825558776,0.4688237015215279
HS2024_4_B_T1,,
MV2014_Ratio M/H normalized A3___1 (10 min),,
SR2019_BT549_Biol_repl_4,,
EJN2021_1_Rest_Basal,,
NJH2025_Sub8_MICT_Post,,
RCJD2014_5min_3,,
CR2017_Ratio Replicate 3.2,0.5325248025868815,0.4459056636386781
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,
GF2025_P7_Adh,0.5511211230283538,
CK2022_9 16-1,,
NJH2024_Sub6_HIIT_Post,,
AMK2021_30R_p3,,
AS2011_Ratio H/L Normalized RNAi_2,,
RM2024_Intensity D0-2___2,,
KS2014_Intensity pY_N4,0.5591210403075091,
CK2022_13 200-1,0.5498926507866085,
AS2011_Ratio H/L Normalized_2,,
PG2020_Intensity 6h_D,0.5492455953706148,0.4584669701362485
CK2022_16 16-1,,
FS2019_db/db3,,
CK2022_15 40-1,,
NJH2024_Sub9_MICT_Pre,,
BS2014_Log2(Ratio H/L unmodified peptide),,
WZ2023_Su_005_10min,0.5444235086032176,0.4656581916308676
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,
KBE2022_Log2_Ex_41_T,0.5517255997170772,
AMK2021_Ctrl_p1,,
AH2018_LFQ_IT_3_X,0.5478236452737841,
HS2024_5_PD_T3,,
AH2018_TMTMS3_3_X,0.5815484770252138,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,
KBE2022_Log2_Ex_40_U,0.5472941311016447,
AH2018_LFQ_M_1_N,0.548398279685841,0.46346266457615315
KBE2022_Log2_Ex_27_U,0.5478351445832387,0.46248888157068724
HW2015_Ratio M/L normalized Exp3,,
RKK2015_TNF-α/IKKb(K44M),,
AH2018_SILAC_M_1_N,0.5501994063354656,
HW2015_Ratio M/L normalized Exp1,,
RB2022_5_RecoveryStrength,,
YP2020_Intensity P10_R1_mult_log2,,
RB2022_7_PreStrength,,
YA2020_Reporter_intensity_Normal_No.4,0.5565523830843613,0.4621662725516329
NJH2025_Sub13_HIIT_Pre,,
PG2020_Intensity CT_D,0.5417581035742971,
NJH2025_Sub9_MICT_Post,,
VOI2024_Veh1 mono,,
CK2022_12 16-1,,
RN2012_L13,,0.4587164582938416
LG2023_Control-1_intensity,0.5498609415897913,
RM2024_Intensity D6-3___2,,
KBE2022_Log2_Ex_8_U,0.54739485258261,
SR2019_SKBR3_Biol_repl_3,,
NJH2024_Sub1_MICT_Post,,
HS2024_3_I_T2,,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,
RM2024_Intensity D0-3___3,,
HS2024_6_I_T2,,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,
AS2011_Ratio H/L Protein Inhi_1,,
FSO2013_Ratio H/M normalized Rep2___1,0.5409804711004486,0.4615518945186361
GRW2016_Ratio M/L normalized SILAC 5a___2,,
CK2022_10 40-1,,
NJH2024_Sub12_HIIT_Pre,,
NJH2024_Sub8_MICT_Pre,,
RM2024_Intensity D0-1___1,,
LY2019_P3+,0.5514691506311247,
HH2022_Reporter intensity 6,0.5520924170339657,
RB2022_2_RecoveryStrength,,
KTGR2014_Ratio-AA 15 mins,,
AS2011_Ratio H/L Normalized RNAi_2_2,,
KS2014_Intensity pY_N3,0.5560404420223244,
MV2014_Ratio H/L normalized B1___2 (30 min),,
LY2019_P5-,0.5453254194071229,
HW2015_Ratio M/L normalized Exp2,,
SR2019_HCC1419_Biol_repl_1,,
AH2018_TMTMS2_3_X,0.5400597100224096,0.47010791886144154
GF2025_P3_Adh,0.5534472226603598,
SR2019_JIMT1_Biol_repl_2,,
AH2018_TMTMS2_1_C,0.5388292346905865,0.46561157947880094
RM2024_Intensity D0-1___2,,
LY2019_P4+,0.541781865917044,
KBE2022_Log2_Ex_19_U,0.5489390935982257,
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,
RB2022_4_PostStrength,,
LG2023_GSK3α-3_intensity,0.5561640123726181,
YA2020_Reporter_intensity_Cancer_No.1,0.5484289402424772,0.46558881909130867
AST2020_Control,0.5469546810653042,0.4645268644432669
JAW2011_Ratio H/L LS1a,,
RCJD2014_5min_mean,,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,
NJH2025_Sub1_MICT_Mid,,
TM2022_S2.12h.C,,
NJH2025_Sub9_MICT_Mid,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,
AS2011_Ratio H/L Normalized Inhi_1_2,,
FSO2013_Ratio M/L normalized Rep2___1,0.5478724821152252,0.47498984544575595
LG2023_Control-2_intensity,0.549819675834337,
NJH2024_Sub8_HIIT_Pre,,
KS2014_Intensity pY_N2,,
RB2022_5_RecoverySprint,,
RB2022_7_RecoverySprint,,
YA2020_Reporter_intensity_Normal_No.3,0.5572252558825578,0.4589225046999917
HS2024_8_B_T2,,
AH2018_LFQ_1_X,0.547347757356064,
RM2024_Intensity D6-1___1,,
RCJD2014_10min_2,,
FR2021_Norm.Intensity.M,,
RM2024_Intensity D0-3___1,,
KS2014_Intensity N2,0.5532684141474632,0.4699926021895631
HH2022_Reporter intensity 1,0.5468682845053161,
HH2022_Reporter intensity 2,0.5463706324326933,
RM2024_Intensity D6-2___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,
RM2024_Intensity D2-3___2,,
YA2020_Reporter_intensity_Normal_No.5,0.5485149098858064,0.4592109731475574
SR2019_MCF7_Biol_repl_1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,
HS2024_8_B_T1,,
NJH2025_Sub6_HIIT_Pre,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,
EP2017_Untreated R#2 log2 ratio,0.5454175927964585,0.46131040311424176
SR2019_LM2_Biol_repl_3,,
RB2022_4_RecoveryStrength,,
CR2017_Ratio Replicate 2,0.5937245606820739,0.45845256758993486
CW2012_10 µM Erl/control Experiment 2 Replicate A,,
FSO2013_Ratio H/M normalized Rep3,0.5482176700898554,0.4664741543712699
AR2021_KD 72h,0.5681297795300468,0.4614341923467189
MV2014_Ratio H/M normalized B2___3 (5 min),,
KBE2022_Log2_Ex_18_U,0.5435660408956712,0.4639976562310531
AS2011_Ratio H/L Inhi_1_1,,
NJH2024_Sub8_MICT_Post,,
AH2018_TMTMS3_3_C,0.577621001976228,
KBE2022_Log2_Ex_9_U,0.5475908564182977,0.4628581792879412
AH2018_SILAC_M_3_N,0.5474072159308668,
KBE2022_Log2_Ex_13_T,0.5472342614881,
RM2024_Intensity D0-3,,
SR2019_SKBR3_Biol_repl_1,,
PG2020_Intensity Mock_10h_C,0.5389993519560312,
CF2017_OSE 29,0.5473662491153675,0.46850575669069705
YB2013_Ratio_H_L_Normalized_in_experiment_1,,
NJH2025_Sub1_HIIT_Post,,
DL2023_24h-2,,
HS2024_7_B_N2,,
PG2020_Intensity 10h_A,,
RN2012_L12,0.5597392162726297,0.46860810953740045
MV2014_Ratio M/L normalized B1___3 (5 min),,
NJH2024_Sub8_MICT_Mid,,
AH2018_LFQ_IT_4_C,0.5456327679474549,
SAS2015_PLX/AZD_Exp1,,
FR2021_Norm.Intensity.A,,
FSO2013_Ratio H/M normalized Rep1___1,0.5417980393127574,0.46964513068487435
JW2015_Intensity cap2,,
BS2014_Log2(Ratio H/L normalized Rep_2),,
NJH2024_Sub6_MICT_Post,,
CK2022_8 40-1,,
RB2022_7_RecoveryEndurance,,
NJH2025_Sub12_HIIT_Post,,
EJN2021_4_Ex_Basal,,
TM2022_S2.12h.B,,
RN2012_L15,,0.47165806316214415
KS2014_Intensity pY_PV3,0.5531185583079945,
TM2022_S2.4h.B,,
PG2020_Intensity 4h_A,0.5481812890766121,
FSO2013_Ratio H/M normalized Rep2___2,0.5545988581947219,0.4875958112494053
TM2022_mock.4h.B,,
KBE2022_Log2_Ex_24_U,0.5477213696457887,
NJH2025_Sub13_MICT_Mid,,
KS2014_Intensity C3,0.5700043339196028,0.46826094906789645
RB2022_1_PreSprint,,
HS2024_4_I_N1,,
CK2022_7 200-1,0.5571732048739348,
CK2022_5 200-1,0.557468101203927,
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,
FSO2013_Ratio H/L normalized Rep2___1,0.5545543808849712,0.4616838497029146
NJH2024_Sub10_HIIT_Mid,,
RB2022_2_PostEndurance,,
AH2018_LFQ_2_C,0.5397289456297318,
AH2018_SILAC_MR_1_X,0.5525403162364234,0.4681686905117622
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,
IMM2018_normalised rep. int. Empty-2,,
RM2024_Intensity D4-1,,
KBE2022_Log2_Ex_25_U,0.5486923056098097,
AH2018_SILAC_3_C,0.5456452704302331,
EJN2021_5_Rest_Ins,,
VOI2024_0.1uM 24 h_3 di,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,
DB2022_LFQ intensity L2.1,,
FSO2013_Ratio H/M normalized Rep1,0.5349585316140394,0.4764886639408014
CK2022_4 16-1,,
AS2011_Ratio H/L,,
SR2019_MCF7_Biol_repl_4,,
EJN2021_2_Ex_Ins,,
AS2011_Ratio H/L Inhi_2_3,,
JAW2011_Ratio H/L LS1a_1,,
AH2018_LFQ_1_N,0.5478136207526629,
SAS2015_PLX/DMSO_Exp1,,
SFR2015_HL_log2_ratio_avg_c,,
JJ2018_Ratio M/L normalized pP2,,
NJH2024_Sub7_MICT_Mid,,
PG2020_Intensity 6h_B,0.5502999245102983,0.45764624033897966
FSO2013_Ratio H/L normalized Rep3,0.5429483753098501,0.4597174094833152
GRW2016_Ratio H/L normalized SILAC 2___2,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,
JJ2018_Ratio M/L normalized,,
KTGR2014_Ratio-AA 30 mins,,
JW2021_After_1,0.5402119699260693,
NJH2025_Sub2_MICT_Mid,,
HS2024_6_B_N2,,
KBE2022_Log2_Ex_9_T,0.5479849699599373,0.4624953879751403
AH2018_SILAC_IT_2_N,0.5481416623621593,
AH2018_SILAC_IT_1_X,0.5483434190351288,
HW2015_Ratio H/L normalized Exp3,,
HS2024_7_PD_T1,,
UK2020_UA_2,,
RM2024_Intensity D2-1___1,,
GF2025_P10_Sph,0.543081661227344,
WZ2023_Pe_025_20min,0.5481012787196081,0.4659099125883063
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,
AH2018_LFQ_2_N,0.5464135664688984,
HS2024_4_I_N2,,
AH2018_TMTMS2_3_N,0.5400670964457845,0.4710935811804384
RN2012_H06,,0.4711346935896193
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
HS2024_4_PD_T3,,
WZ2023_Su_005_30min,0.5414695253488174,0.4652347832758654
SR2019_HCC1419_Biol_repl_4,,
JJ2018_Ratio H/M normalized___2,,
SR2019_JIMT1_Biol_repl_3,,
AS2011_Ratio H/L Protein,,
UK2020_HCM_3,,
NJH2024_Sub10_HIIT_Post,,
CR2017_Ratio Replicate 3.1,0.5036780547743652,0.4951551847465578
WZ2023_Su_025_10min,0.5407645484543034,0.46441441844630454
AH2018_LFQ_IT_4_X,0.5475306128457207,
CP2009_Ratio H/L,,
VOI2024_0.1uM 24 h_3 mono,,
RB2022_4_RecoverySprint,,
RM2024_Intensity D6-3,,
WZ2023_Su_005_20min,0.5449078325405665,0.46528427084528573
CW2012_10 µM Gef/control Experiment 1 Replicate B,,
SFR2015_HL_log2_ratio_avg_a,,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,
RB2022_1_PreEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,
LG2023_GSK3α-2_intensity,0.5537877954261384,
EP2017_Pervanadate R#1 log2 ratio,0.5486242521781897,0.47808513935338304
NJH2025_Sub6_HIIT_Post,,
RB2022_6_RecoverySprint,,
KS2014_Intensity,0.5791567411128138,0.4693430683219253
MV2014_Ratio H/M normalized A2___1 (2 min),,
PG2020_Intensity 8h_D,0.5513349280178322,0.462861387006152
LY2019_P7+,0.5527243144906708,
EP2017_Untreated R#1 normalized log2 ratio,0.5490911871277809,0.4567237315827131
RN2012_L10,,
PG2020_Intensity 4h_C,0.5417273514963982,
EP2017_Mitotic R#3 normalized log2 ratio,0.556652415976322,0.4557673101870996
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,
DB2022_LFQ intensity L1,,
KBE2022_Log2_Ex_24_T,0.5478535944731647,
RB2022_8_PostStrength,,
AH2018_SILAC_IT_2_X,0.548480737654665,
HS2024_4_B_T3,,
NJH2024_Sub2_HIIT_Post,,
HS2024_8_B_N2,,
NJH2025_Sub8_HIIT_Pre,,
JJ2018_Ratio H/L normalized pP2___1,,
HS2024_8_I_T2,,
KBE2022_Log2_Ex_6_U,0.5478087045146344,
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,
CR2017_Ratio Replicate 1.1,0.5828263517490219,0.46791087643448975
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,
MV2014_Ratio M/H normalized B3___2 (30 min),,
CK2022_16 200-1,0.5471756127074434,
VOI2024_0.1uM 2 h_3 di,,
EP2017_Mitotic R#1 normalized log2 ratio,0.5536767496174914,0.45367868223830754
GF2025_P9_Sph,0.5443944206214282,
CK2022_6 200-1,0.5582057120054735,
NJH2024_Sub7_MICT_Post,,
AH2018_TMTMS3_2_X,0.5808195020823915,
NJH2024_Sub8_HIIT_Post,,
DB2022_LFQ intensity R1,,
JW2015_Intensity cap3,,
SR2019_HCC1954_Biol_repl_1,,
HS2024_4_I_T2,,
NJH2024_Sub2_MICT_Mid,,
VOI2024_0.1uM 2 h_2 mono,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,
HS2024_4_PD_T1,,
SAS2015_AZD/DMSO_Exp1,,
NJH2024_Sub1_MICT_Mid,,
IMM2018_normalised rep. int. CDK5L-3,,
HS2024_3_B_T3,,
MV2014_Ratio L/H normalized A3___2 (2 min),,
NJH2025_Sub13_MICT_Pre,,
SR2019_MDAMB231_Biol_repl_3,,
GRW2016_Ratio H/L normalized SILAC 4___1,,
MM2018_Ratio H/L replicate1,,
PG2020_Intensity 2h_D,0.533789900335419,
EP2017_Untreated R#3 normalized log2 ratio,0.559107533070396,0.4501512991241422
MV2014_Ratio M/H normalized A3___3 (10 min),,
NJH2024_Sub7_HIIT_Pre,,
JAW2011_Ratio H/L LS2,,
CK2022_8 200-1,0.5569810839587256,
KS2014_Intensity pY_C4,,
CR2017_Ratio Replicate 3.5,0.5817712351751746,0.44940092290503486
RB2022_7_PostEndurance,,
NJH2025_Sub4_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,
TM2022_mock.12h.A,,
JJ2018_Ratio H/L normalized pP1,,
EP2017_Pervanadate R#2 normalized log2 ratio,0.5405995706114705,0.4613561766877978
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,
KS2014_Intensity pY_E5_4,,
RM2024_Intensity D4-3___2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,
AH2018_SILAC_2_C,0.5463140819464555,
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
HS2024_7_I_N1,,
KBE2022_Log2_Ex_29_T,0.5448828263612275,0.46202165025032804
HS2024_7_I_T2,,
AS2011_Ratio H/L Normalized RNAi_2_3,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,
HS2024_6_B_T2,,
AMK2021_45I_p5,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,
SAS2015_PLX/DMSO_Exp2,,
EJN2021_1_Ex_Basal,,
FR2021_Intensity.M,,
RB2022_2_PostSprint,,
AH2018_SILAC_MR_3_N,,0.46899026686710177
MV2014_Ratio H/L normalized B1___3 (30 min),,
CF2017_FTE 13,0.5448549942662921,0.45587264436267344
PG2020_Intensity CT_C,0.5454802201280022,
ZCP2016_Ratio H/L Rep 1,,
FS2019_db/db2,,
KS2014_Intensity pY_PV4,0.5540174323582584,
KBE2022_Log2_Ex_39_U,0.5482349695725575,
EP2017_Untreated R#3 log2 ratio,0.5587821629008297,0.44987796884068815
RB2022_2_PostStrength,,
AS2011_Ratio H/L Normalized_1,,
MV2014_Ratio M/H normalized A3___2 (10 min),,
CR2017_Ratio Replicate 3.4,0.5085836647684299,0.4500779073576522
HS2024_8_PD_T2,,
FS2019_Ctr2,,
RB2022_6_PreEndurance,,
FR2021_Norm.Intensity.G,,
NJH2025_Sub9_HIIT_Post,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,
RM2024_Intensity D4-3,,
HS2024_8_B_N1,,
NJH2025_Sub10_MICT_Mid,,
KBE2022_Log2_Ex_15_U,0.5485925760420596,
AS2011_Ratio H/L Normalized Inhi_2,,
RKK2015_TNF-α/SC-514,,
RB2022_3_PreSprint,,
CR2017_Ratio Replicate 2.3,0.5235499629073432,0.44774630475507254
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,
GF2025_P4_Adh,0.5500030912050196,
YA2020_Reporter_intensity_Normal_No.2,0.5478205590756423,0.46027103058043717
YP2020_Intensity P30_R2_mult_log2,,
NJH2025_Sub13_MICT_Post,,
HS2024_4_B_N2,,
HS2024_3_PD_T3,,
AMK2021_120R_p3,,
MV2014_Ratio L/H normalized A3___3 (2 min),,
NJH2025_Sub10_HIIT_Pre,,
FR2021_Intensity.G,,
RAM2015_Log2 C,0.548334081735004,0.4767408305759245
AS2011_Ratio H/L Proteins Inhi_1,,
FSO2013_Ratio H/M normalized Rep1___3,0.534721447334835,0.48582388955668215
AH2018_LFQ_M_2_N,0.545812130676926,0.4624228433084336
MV2014_Ratio M/L normalized A1___3 (2 min),,
KBE2022_Log2_Ex_40_T,0.5471569116760974,
CK2022_2 16-1,,
RAM2015_Log2 B,0.5436759667337377,0.4628042143156439
YP2020_Intensity C10_R1_mult_log2,,
FSO2013_Ratio M/L normalized Rep1___2,0.5456850815141475,0.4578892689047446
NJH2025_Sub8_MICT_Pre,,
EJN2021_4_Rest_Basal,,
YB2013_Ratio_H_L_Normalized_in_experiment_2,,
JJ2018_Ratio H/M normalized pP3___1,,
VOI2024_Veh2 mono,,
HS2024_6_B_T1,,
UK2020_HCM_5,,
NJH2025_Sub10_HIIT_Post,,
VOI2024_0.1uM 2 h_3 mono,,
JW2015_Intensity pre3,,
AS2011_Ratio H/L Normalized Inhi_2_1,,
DL2023_24h-3,,
HS2024_7_PD_T3,,
PG2020_Intensity Mock_10h_B,,
WZ2023_Su_025_30min,0.5428552889805245,0.4647253683189446
AH2018_LFQ_4_N,0.545947898134701,
CR2017_Ratio Replicate 1.2,0.5929465634313934,0.44121537630231844
AS2011_Ratio H/L Normalized by Proteins,,
RB2022_6_RecoveryStrength,,
HS2024_8_I_N1,,
AMK2021_Ctrl_p3,,
AS2011_Ratio H/L Protein Inhi_2,,
HH2022_Reporter intensity 7,0.5531833469911946,
AH2018_SILAC_M_1_X,0.5537826348450684,
RB2022_7_PreEndurance,,
VOI2024_0.1uM 24 h_2 di,,
DL2023_control-2,,
LY2019_P6+,0.5516354689681996,
DB2022_LFQ intensity R2,,
GF2025_P6_Adh,0.5594992431095986,
VOI2024_Veh1 di,,
AS2011_Ratio H/L RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,
VOI2024_Veh3 mono,,
HS2024_5_I_T2,,
NJH2025_Sub7_HIIT_Mid,,
MV2014_Ratio H/L normalized B1___1 (30 min),,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,
RB2022_6_PostSprint,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,
AS2011_Ratio H/L Inhi_1,,
AS2011_Ratio H/L Normalized RNAi_1_2,,
AH2018_TMTMS3_2_C,0.5821604934590545,
SR2019_Hs578T_Biol_repl_4,,
RB2022_8_PreStrength,,
KS2014_Intensity C5,0.5744999982295431,0.46991402930397247
RM2024_Intensity D0-1,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,
YP2020_Intensity P30_R1_mult_log2,,
NJH2025_Sub2_HIIT_Pre,,
RB2022_3_RecoveryEndurance,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,
GF2025_P9_Adh,0.55850645667112,
RB2022_3_PostStrength,,
TM2022_S2.8h.A,,
AS2011_Ratio H/L RNAi_1_1,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,
NJH2025_Sub2_MICT_Pre,,
MV2014_Ratio L/M normalized A2___3 (10 min),,
MV2014_Ratio H/M normalized A2___3 (2 min),,
HS2024_4_B_T2,,
SR2019_BT549_Biol_repl_1,,
AH2018_LFQ_M_4_N,0.5465910595161182,
NJH2024_Sub8_HIIT_Mid,,
PG2020_Intensity 8h_B,0.5441668422779639,0.4635565921423773
AH2018_LFQ_2_X,0.549248238908466,0.45919938461351756
PG2020_Intensity 2h_B,0.5378475597875986,
AS2011_Ratio H/L Proteins RNAi_1,,
RB2022_4_PostSprint,,
KS2014_Intensity E15_3,0.5701442314242765,
GF2025_P3_Sph,0.5503068602939434,
DB2022_LFQ intensity L2,,
MV2014_Ratio H/L normalized A1___1 (10 min),,
AH2018_SILAC_1_C,0.5482127784482532,
NJH2024_Sub1_HIIT_Pre,,
FSO2013_Ratio M/L normalized Rep2___2,0.5591410997846802,0.47525595958447453
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,
AS2011_Ratio H/L RNAi_2_3,,
AH2018_SILAC_IT_1_N,0.5479182466035611,
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,
RB2022_4_PreEndurance,,
JJ2018_Ratio M/L normalized pP1,,
CR2017_Ratio Replicate 2.4,0.5948506628636654,0.4577276352090065
ZQ2022_N1,0.5461121898087707,
LY2019_P6-,0.5507242325832453,
RM2024_Intensity D2-3,,
UK2020_HCM_1,,
JW2015_Intensity pre2,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,
RM2024_Intensity D2-1,,
NJH2025_Sub12_MICT_Post,,
MV2014_Ratio H/M normalized B2___2 (5 min),,
RN2012_L14,,0.46288926927519264
AH2018_LFQ_3_N,0.5456842704236554,
RKK2015_TNF-α/IKKb,,
SFR2015_HL_log2_ratio_std_b,,
UK2020_UA_1,,
KBE2022_Log2_Ex_13_U,0.54780746771039,
AS2011_Ratio H/L Normalized Inhi_1,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,
RB2022_1_RecoverySprint,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,
JJ2018_Ratio H/L normalized pP3,,
CK2022_7 40-1,,
AS2011_Ratio H/L Inhi_1_3,,
NJH2025_Sub10_HIIT_Mid,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,
JAW2011_Ratio H/L LS1b_1,,
PG2020_Intensity 4h_B,0.5429249109628173,
SR2019_BT549_Biol_repl_2,,
RM2024_Intensity D4-2,,
DB2022_LFQ intensity R2.2,,
JJ2018_Ratio H/L normalized,,
RB2022_5_PostEndurance,,
HS2024_5_PD_T2,,
WZ2023_Su_025_20min,0.543387963792329,0.4647096276683449
RM2024_Intensity D2-2___1,,
IMM2018_normalised rep. int. CDK5L-2,,
LY2019_P8-,0.5560685476106412,
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,
FSO2013_Ratio H/L normalized Rep1,0.5484763705953861,0.46573571686719745
NJH2024_Sub2_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,
CK2022_13 40-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,
RN2012_H02,,
PG2020_Intensity 10h_D,,0.4487987295179917
RB2022_8_PreEndurance,,
HS2024_3_B_N2,,
EJN2021_4_Ex_Ins,,
AS2011_Ratio H/L Normalized by Protein,,
EJN2021_1_Ex_Ins,,
EP2017_Pervanadate R#3 log2 ratio,0.5484219725930429,0.46793263304866506
FSO2013_Ratio M/L normalized Rep1___3,0.5608430978191692,0.45046709936203766
NJH2025_Sub4_HIIT_Mid,,
RCJD2014_5min_2,,
RB2022_6_PostStrength,,
AH2018_SILAC_MR_3_C,,0.4690201177556139
AH2018_LFQ_M_4_C,0.540052258826923,0.46410725360964405
NJH2024_Sub4_MICT_Pre,,
AS2011_Ratio H/L Normalized Inhi_1_1,,
DL2023_12h-1,,
MV2014_Ratio L/M normalized B2___1 (30 min),,
DB2022_LFQ intensity L1.1,,
NJH2025_Sub6_MICT_Pre,,
NJH2025_Sub6_MICT_Post,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,
RN2012_H04,,0.46590507040018625
CK2022_6 40-1,,
DB2022_LFQ intensity R2.1,,
KBE2022_Log2_Ex_42_U,0.5486841887203868,
LY2019_P3-,0.5578275536301865,
FR2021_Intensity.A,,
EJN2021_3_Ex_Ins,,
MV2014_Ratio M/L normalized A1___1 (2 min),,
WZ2023_Pe_005_30min,0.5458975095730211,0.4655465293330628
HS2024_8_PD_T3,,
EJN2021_3_Ex_Basal,,
AST2020_Control.1,0.5467480522638932,0.46438069980874036
JW2015_Intensity cap1,,
PG2020_Intensity CT_A,0.541044611357576,
FS2019_Ctr3,,
WZ2023_Pu_025_20min,0.5403315458222739,0.46511762483301133
NJH2025_Sub4_MICT_Post,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,
GF2025_P10_Adh,0.5439273000959784,
RB2022_1_RecoveryStrength,,
SR2019_HCC1954_Biol_repl_4,,
FR2021_Norm.Intensity.N,,
HS2024_5_B_N1,,
FSO2013_Ratio H/M normalized Rep3___3,0.5504842646929874,0.4557454325891941
AH2018_TMTMS2_2_C,0.5411853820586529,0.46779269135785156
RB2022_4_PreSprint,,
DB2022_Intensity R2,,
AH2018_TMTMS2_Pool,0.578329760408186,
HS2024_8_I_N2,,
RB2022_3_RecoveryStrength,,
NJH2024_Sub6_HIIT_Mid,,
AH2018_SILAC_M_1_C,0.5495470030882141,
LY2019_P8+,0.5495005344225186,
RB2022_2_RecoveryEndurance,,
JJ2018_Ratio H/M normalized pP2___1,,
JAW2011_Ratio H/L HS_1,,
RB2022_3_PostEndurance,,
KS2014_Intensity pY_PV1,0.551149294515332,
JAW2011_Ratio H/L LS1b_2,,
SR2019_MCF7_Biol_repl_2,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),,
AS2011_Ratio H/L Normalized RNAi_1_1,,
AH2018_LFQ_M_4_X,0.5408203511772173,0.4617886927869197
NJH2024_Sub6_MICT_Pre,,
JJ2018_Ratio M/L normalized pP1___2,,
YP2020_Intensity C30_R2_mult_log2,,
NJH2024_Sub9_HIIT_Pre,,
AS2011_Ratio H/L Normalized Inhi_2_3,,
RM2024_Intensity D0-1___3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,
KBE2022_Log2_Ex_28_U,0.5479842505360331,
GRW2016_Ratio H/L normalized SILAC 1___1,,
CF2017_FTE 17,0.5495353031253045,0.4696542361856417
LY2019_P2-,0.5620719378149217,
AH2018_LFQ_IT_1_X,0.5530966443024868,
JJ2018_Ratio H/L normalized pP3___1,,
RB2022_8_RecoveryStrength,,
WZ2023_Pe_005_20min,0.5392008120252163,0.4658546790382462
AST2020_Control.2,0.5466476159693354,0.4644718572950016
NJH2025_Sub6_MICT_Mid,,
RCJD2014_10min_1,,
FSO2013_Ratio H/L normalized Rep2___3,0.5277265212412772,0.4594763105458375
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,
HS2024_3_I_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,
CK2022_4 40-1,,
SR2019_MCF10A_Biol_repl_4,,
KS2014_Intensity pY_C5,,
NJH2025_Sub4_MICT_Pre,,
NJH2024_Sub9_MICT_Post,,
CF2017_OSE 28,0.5467769569840033,
HS2024_5_B_T2,,
HS2024_6_I_T1,,
HS2024_5_B_T3,,
JJ2018_Ratio H/M normalized pP1___1,,
KBE2022_Log2_Ex_36_U,0.5473692968210557,0.46475187979734606
AH2018_TMTMS3_3_N,0.5786109062215259,
SR2019_HCC1419_Biol_repl_2,,
FR2021_Intensity.N,,
AS2011_Ratio H/L Inhi_2_1,,
AH2018_SILAC_MR_1_C,0.5525162413224172,0.4596211259581179
NJH2024_Sub1_HIIT_Mid,,
NJH2025_Sub8_HIIT_Mid,,
EP2017_Mitotic R#3 log2 ratio,0.5553885138198905,0.4550679583839068
KBE2022_Log2_Ex_36_T,0.5458159347724671,0.4646595594875943
NJH2025_Sub6_HIIT_Mid,,
WZ2023_Pu_005_30min,0.5469636312862837,0.4658154847813
KS2014_Intensity C2,0.5541232422138733,0.4704372712431989
FSO2013_Ratio H/L normalized Rep1___2,0.5335459009707991,0.4435091072462767
RM2024_Intensity D2-2,,
KBE2022_Log2_Ex_42_T,0.548099891955631,
CK2022_9 200-1,0.5530420070232771,
GRW2016_Ratio H/L normalized SILAC 2___1,,
JJ2018_Ratio H/M normalized pP3___2,,
DB2022_LFQ intensity R1.1,,
CK2022_10 200-1,0.5538594976220389,
NJH2024_Sub9_MICT_Mid,,
JAW2011_Ratio H/L_2,,
HS2024_7_I_N2,,
RBK2021_1332T Late,,
LY2019_P1-,0.5366460401766777,
RKK2015_TNF-α/basal.1,,
RKK2015_TNF-α/TNF-α+SC-514,,
CR2017_Ratio Replicate 2.5,0.5831877526681445,0.4537924570874812
HS2024_3_I_T3,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,
AS2011_Ratio H/L Normalized RNAi_1,,
KS2014_Intensity E15_4,0.5669506476349789,
ZQ2022_C3,0.5544462832296086,
EJN2021_3_Rest_Ins,,
YP2020_Intensity P10_R2_mult_log2,,
MV2014_Ratio H/L normalized A1___3 (10 min),,
NJH2025_Sub1_MICT_Pre,,
KBE2022_Log2_Ex_39_T,0.5477449520692749,
FSO2013_Ratio H/M normalized Rep3___2,0.5611022387626591,0.48711701933791585
RM2024_Intensity D6-2,,
EP2017_Untreated R#1 log2 ratio,0.5487479895484876,0.4564265191381333
RKK2015_SC-514/basal,,
RM2024_Intensity D6-1___3,,
WZ2023_Pu_010_10min,0.5431415237436391,0.4656502712021596
NJH2025_Sub9_HIIT_Mid,,
SR2019_SKBR3_Biol_repl_4,,
HS2024_5_I_T3,,
KS2014_Intensity N1,0.5619961583796274,0.46733399644385337
NJH2024_Sub12_MICT_Post,,
TM2022_S2.8h.C,,
CR2017_Ratio Replicate 1,0.5675152079502463,0.46880941298094647
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,
JJ2018_Ratio H/M normalized pP3,,
AH2018_SILAC_MR_2_C,0.5474533999355118,0.46835240374339343
LATM2013_Log2 Ratio (Medium/Light) Forward,,
PG2020_Intensity 2h_A,,
NJH2024_Sub6_MICT_Mid,,
NJH2025_Sub13_HIIT_Post,,
AH2018_SILAC_MR_3_X,,0.4687258258038071
JJ2018_Ratio H/M normalized___1,,
RCJD2014_15min_2,,
AS2011_Ratio H/L_2,,
AS2011_Ratio H/L Normalized,,
RN2012_H03,0.5584943584249307,0.47288896989026735
HS2024_5_B_N2,,
HS2024_5_I_N1,,
HS2024_6_I_N1,,
AR2021_KD 48h,0.5441922233574281,0.4437883657897493
FR2021_Intensity.B,,
RB2022_3_PreEndurance,,
HS2024_5_I_T1,,
NJH2024_Sub10_MICT_Pre,,
SR2019_LM2_Biol_repl_2,,
AST2020_anti-CD3,0.5468667274803498,0.46464652024582265
SR2019_MDAMB231_Biol_repl_1,,
RM2024_Intensity D2-3___3,,
WZ2023_Pe_005_10min,0.5404296790138506,0.4652544489777499
KBE2022_Log2_Ex_29_U,0.5459832262852377,0.4624118818451929
HS2024_7_B_T1,,
AH2018_LFQ_M_2_X,0.5504416678700758,0.46218109166026483
AH2018_LFQ_IT_4_N,0.5468937925398922,
CK2022_15 200-1,0.5492571231690412,
RM2024_Intensity D4-1___2,,
JJ2018_Ratio H/M normalized,,
JJ2018_Ratio M/L normalized pP3___1,,
KBE2022_Log2_Ex_34_T,0.548914430926499,
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,
LY2019_P2+,0.5547513351430902,
LATM2013_Log2 Ratio (Light/Medium) Reverse,,
CK2022_2 200-1,0.5616031106676598,
AS2011_Ratio H/L Protein RNAi_2,,
MV2014_Ratio L/H normalized A3___1 (2 min),,
WZ2023_Su_010_30min,0.5437515615080543,0.4653630105682159
RN2012_H01,,
KTGR2014_Ratio-Rapa 2 mins,,
EJN2021_2_Rest_Basal,,
KS2014_Intensity pY_E5_3,,
MM2018_Ratio H/L replicate 3,,
EP2017_Pervanadate R#1 normalized log2 ratio,0.5483182379406442,0.4777155147865634
HS2024_8_B_T3,,
YA2020_Reporter_intensity_Cancer_No.3,0.5464641375301535,0.46053482837930204
KBE2022_Log2_Ex_44_U,0.5498441988392299,
WZ2023_Pe_010_20min,0.5398183861724839,0.4657138110524378
KS2014_Intensity pY_C6,0.544641429753051,
AS2011_Ratio H/L Normalized_3,,
RCJD2014_15min_mean,,
RB2022_3_PreStrength,,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,
RCJD2014_10min_mean,,
KS2014_Intensity C1,0.571012532893091,0.464346334571176
FSO2013_Ratio H/M normalized Rep3___1,0.5473016716028793,0.45508766892471275
AH2018_SILAC_M_3_C,0.5462103863327129,
RKK2015_TNF-α+IKKb/TNF-α,,
RM2024_Intensity D0-3___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,
AH2018_SILAC_M_2_C,0.5476574511960057,
AH2018_SILAC_M_2_X,0.5474524782807624,
KTGR2014_Ratio-Rapa 15 mins,,
RM2024_Intensity D4-2___1,,
KBE2022_Log2_Ex_15_T,0.5484514390838316,
VOI2024_0.1uM 24 h_1 di,,
WZ2023_Su_010_10min,0.5424422897828329,0.46495886365423655
PG2020_Intensity 6h_C,0.5485960401410244,0.4583977386718069
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,
JJ2018_Ratio M/L normalized pP1___1,,
AH2018_LFQ_M_3_N,0.5434966901562558,
VOI2024_0.1uM 24 h_2 mono,,
AH2018_TMTMS2_3_C,0.5413666747527329,0.4693375862725928
CK2022_15 16-1,,
CK2022_3 16-1,,
LY2019_P4-,0.5455616403021608,
FSO2013_Ratio H/L normalized Rep3___2,0.5553091880019289,0.46971982474446894
KS2014_Intensity pY_PV2,0.5529038292742391,
HS2024_3_I_N2,,
GF2025_P8_Adh,0.5584613035281557,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,
GF2025_P5_Sph,0.5520465376885896,
CK2022_10 16-1,,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,
VOI2024_0.1uM 2 h_2 di,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,
NJH2024_Sub2_HIIT_Mid,,
AMK2021_45I_p3,,
NJH2024_Sub13_HIIT_Mid,,
DB2022_LFQ intensity R1.2,,
DB2022_Intensity R1,,
NJH2024_Sub12_MICT_Mid,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,
UK2020_HCM_4,,
SAS2015_AZD/DMSO_Exp2,,
IMM2018_normalised rep. int. CDK5L-1,,
DB2022_LFQ intensity L2.2,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,
EP2017_Mitotic R#1 log2 ratio,0.5515596477522705,0.45186200039555247
EJN2021_2_Ex_Basal,,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,
KTGR2014_Ratio-Rapa 30 mins,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,
CF2017_FTE 16,0.54805435203874,0.4626061185734145
AR2021_L41 10 μM,0.5564135488723179,0.47475507466904104
CF2017_EOC 2,0.544263056021226,0.4584093723754052
RB2022_6_PostEndurance,,
AH2018_SILAC_1_N,0.5507833459394754,
NJH2024_Sub10_HIIT_Pre,,
AS2011_Ratio H/L Inhi_1_2,,
UK2020_HCM_6,,
RB2022_7_PreSprint,,
NJH2024_Sub2_MICT_Pre,,
HS2024_3_PD_T2,,
CK2022_6 16-1,,
ZX2022_CB treated Replicate 1,,
BS2014_Log2(Ratio H/L normalized Rep_3),,
TM2022_mock.12h.C,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,
HH2022_Reporter intensity 0,0.5470227569063322,
RM2024_Intensity D2-2___2,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,
RB2022_1_PreStrength,,
JJ2018_Ratio H/M normalized pP2___2,,
AH2018_TMTMS2_2_X,0.5396742181494164,0.4674105702013845
AR2021_L41 1 μM,0.570547556626051,0.4808993682365532
JJ2018_Ratio H/M normalized pP1___2,,
AH2018_TMTMS2_1_N,0.5414066096102785,0.4648237868967443
NJH2025_Sub10_MICT_Pre,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,
ZX2022_Control Replicate 3,,
KS2014_Intensity C4,0.5655154115340278,0.47114323161741695
AS2011_Ratio H/L Inhi_2,,
KBE2022_Log2_Ex_18_T,0.543088794059223,0.46340380277103904
NJH2025_Sub9_MICT_Pre,,
RCJD2014_20min_1,,
MV2014_Ratio H/M normalized B2___1 (5 min),,
FSO2013_Ratio M/L normalized Rep2___3,0.5521476919451642,0.4819994631188609
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,
SR2019_MCF10A_Biol_repl_3,,
HS2024_7_B_T2,,
SAS2015_PLX/DMSO_Exp3,,
AMK2021_Ctrl_p5,,
NJH2025_Sub2_HIIT_Mid,,
AH2018_LFQ_M_3_C,0.5458745125706851,
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,
YA2020_Reporter_intensity_Cancer_No.2,0.5441636383049249,0.46279857486503573
FSO2013_Ratio H/M normalized Rep2___3,0.540969846812404,0.4844919828385135
RB2022_8_PreSprint,,
AH2018_SILAC_IT_3_C,0.5460851763163017,
WZ2023_Pu_025_10min,0.5462970911467513,0.46527335177921203
RM2024_Intensity D2-2___3,,
AS2011_Ratio H/L_1,,
RCJD2014_10min_3,,
FSO2013_Ratio M/L normalized Rep3___1,0.5400479799300956,0.4698940715032299
SR2019_JIMT1_Biol_repl_4,,
YP2020_Intensity C10_R2_mult_log2,,
ZCP2016_Ratio H/L Rep 2,,
CF2017_EOC 4,0.5487600719888259,
JJ2018_Ratio H/L normalized pP1___1,,
WZ2023_Pe_010_30min,0.5432249073568512,0.46608590853040777
MV2014_Ratio L/M normalized B2___3 (30 min),,
AH2018_LFQ_IT_3_N,0.547010644629873,
KS2014_Intensity C6,0.5589334874918819,0.46392217455373314
ZQ2022_N3,0.5425225978335622,
HW2015_Ratio H/L normalized Exp1,,
CK2022_12 40-1,,
NJH2024_Sub7_MICT_Pre,,
ZX2022_Control Replicate 1,,
JJ2018_Ratio H/M normalized pP1,,
CK2022_16 40-1,,
AH2018_SILAC_IT_2_C,0.5470899402932607,
CK2022_5 40-1,,
AH2018_LFQ_3_X,0.5461993057384272,
UK2020_UA_3,,
LY2019_P7-,0.545947582545823,
GF2025_P5_Adh,0.5481364997144921,
RB2022_1_PostStrength,,
JAW2011_Ratio H/L LS1b,,
FSO2013_Ratio H/L normalized Rep3___1,0.5527054364238713,0.46062211830912286
SR2019_HCC1954_Biol_repl_3,,
CR2017_Ratio Replicate 2.2,0.5910487406114205,0.43174898435922215
VOI2024_0.1uM 2 h_1 mono,,
MV2014_Ratio L/M normalized A2___1 (10 min),,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,
CK2022_11 16-1,,
ZQ2022_C1,0.5527667369517125,
CR2017_Ratio Replicate 2.1,0.5595322241816848,0.448039975774953
PG2020_Intensity CT_B,0.5334924409973353,
JJ2018_Ratio M/L normalized___2,,
AH2018_SILAC_MR_1_N,0.549774434183989,0.46041898603618747
KS2014_Intensity pY_E5_1,,
JW2021_Before_3,0.560148101384185,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,
MV2014_Ratio M/H normalized B3___3 (30 min),,
FS2019_db/db1,,
NJH2025_Sub9_HIIT_Pre,,
JAW2011_Ratio H/L_1,,
RCJD2014_20min_3,,
AH2018_LFQ_3_C,0.5478840932159721,
JJ2018_Ratio M/L normalized pP3___2,,
AMK2021_45I_p1,,
NJH2025_Sub8_HIIT_Post,,
AH2018_LFQ_M_3_X,0.5486703190504328,
YA2020_Reporter_intensity_Cancer_No.4,0.5455964201611525,0.4626856492633633
KS2014_Intensity pY_E5_2,,
FSO2013_Ratio H/L normalized Rep1___3,0.5544311733934859,0.470881486740565
GF2025_P4_Sph,0.5515723096744968,
RB2022_2_PreEndurance,,
JW2021_Before_1,0.5601538028134594,
KBE2022_Log2_Ex_25_T,0.5481089998840825,
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,
MV2014_Ratio L/M normalized A2___2 (10 min),,
JJ2018_Ratio M/L normalized___1,,
FR2021_Intensity.H,,
CK2022_14 16-1,,
AST2020_anti-CD3+PDL2,0.5470654407012746,0.46524743170720867
MV2014_Ratio M/L normalized B1___1 (5 min),,
KBE2022_Log2_Ex_19_T,0.5485820414706396,
KS2014_Intensity pY_N1,0.5559110694546212,
RB2022_1_RecoveryEndurance,,
FSO2013_Ratio H/M normalized Rep1___2,0.5444123662513296,0.48110374570210035
HS2024_8_I_T1,,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,
EP2017_Mitotic R#2 log2 ratio,0.5539350523288732,0.45389513842647145
AH2018_TMTMS2_1_X,0.54213451096426,0.4664829672380514
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,
ZCP2016_Ratio H/L Rep 3,,
AS2011_Ratio H/L Normalized RNAi_1_3,,
SR2019_MCF10A_Biol_repl_1,,
NJH2025_Sub8_MICT_Mid,,
EJN2021_5_Ex_Ins,,
HS2024_6_I_N2,,
HH2022_Reporter intensity 4,0.5515641011209311,
RBK2021_1326T Late,,
TM2022_mock.12h.B,,
NJH2024_Sub12_MICT_Pre,,
RCJD2014_15min_3,,
MV2014_Ratio L/H normalized B3___2 (5 min),,
LG2023_Control-3_intensity,0.5498205585203102,
JJ2018_Ratio H/L normalized pP3___2,,
CF2017_FTE 15,0.5485632615480922,0.4589762116303646
HS2024_4_I_T3,,
AH2018_SILAC_1_X,0.5530860230848478,
PG2020_Intensity 10h_B,0.5456072554086114,
AH2018_TMTMS3_1_X,0.5772691946870944,
CF2017_FTE 14,0.5499461686720324,0.467534742914661
NJH2024_Sub13_HIIT_Post,,
RM2024_Intensity D6-3___3,,
NJH2025_Sub7_HIIT_Pre,,
RBK2021_1259T Early,,
RKK2015_IKK+TNF-α/IKKb,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,
PG2020_Intensity 6h_A,0.5485477096710667,0.4589214027054152
SR2019_HCC1419_Biol_repl_3,,
KBE2022_Log2_Ex_14_T,0.5476552597755711,
EP2017_Untreated R#2 normalized log2 ratio,0.5456920842127652,0.4615438713192764
RM2024_Intensity D0-2___1,,
DB2022_Intensity L1,,
LY2019_P5+,0.5363680233731692,
HS2024_5_I_N2,,
SAS2015_PLX/AZD_Exp3,,
EP2017_Pervanadate R#2 log2 ratio,0.5411679821070539,0.4618940024206053
AS2011_Ratio H/L Normalized RNAi_2_1,,
